InvestorsHub Logo
Post# of 252107
Next 10
Followers 832
Posts 119787
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 189252

Tuesday, 03/29/2016 9:34:48 AM

Tuesday, March 29, 2016 9:34:48 AM

Post# of 252107
OHRP +17% on SPA for phase-3 Squalamine trial in wet AMD:

http://finance.yahoo.com/news/ohr-pharmaceutical-inc-announces-spa-110000764.html

Caution: OHRP is proceeding to phase-3 despite missing the primary endpoint in phase-2—see #msg-112155291 for background.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.